SCHEMBL7683407

SCHEMBL7683407

COc1nc2cc(Cl)c(Cl)c(C(=O)N=CN(C)C)c2nc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.36
HTT P42858 2/20 0.36
ALDH1A1 P00352 5/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
ATM Q13315 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676275 0.78 ALDH1A1 (0.39) POLBALDH1A1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL7679349 0.77 POLB (0.43) POLBHTTALDH1A1HPGDNPSR1
SCHEMBL7676315 0.75 ALDH1A1 (0.40) POLBHTTALDH1A1HPGDSMN1; SMN2
SCHEMBL7676314 0.71 HPGD (0.45) POLBALDH1A1MEN1KMT2AHPGD
SCHEMBL24569195 0.70 HTT (0.33) POLBHTTALDH1A1L3MBTL1MEN1
SCHEMBL29670605 0.70 HTT (0.33) POLBHTTALDH1A1L3MBTL1MEN1
SCHEMBL16583573 0.69 POLB (0.39) POLBHTTALDH1A1L3MBTL1HPGD
SCHEMBL16583571 0.69 POLB (0.39) POLBHTTALDH1A1L3MBTL1HPGD
SCHEMBL7820043 0.68 HRH4 (0.35) HRH4CYP1A2CYP2C19
SCHEMBL7473964 0.67 HRH4 (0.39) MEN1KMT2AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed